| P2093 | author name string | Finberg R | |
| P2860 | cites work | Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone | Q36259646 |
| | Anti-influenza response achieved by immunization with a synthetic conjugate | Q36278500 |
| | A T helper cell for anti-viral cytotoxic T-cell responses | Q36342983 |
| | Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition | Q36344766 |
| | Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions | Q36345424 |
| | Idiotypy of clonal responses to influenza virus hemagglutinin | Q36345786 |
| | Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity | Q36348121 |
| | Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function | Q36380138 |
| | Type-specific reovirus antiserum blocks the cytotoxic T-cell-target cell interaction: evidence for the association of the viral hemagglutinin of a nonenveloped virus with the cell surface | Q36442603 |
| | T cell response to viral and bacterial infection. | Q39874435 |
| | T-Cell-Mediated Immunopathology in Viral Infections | Q39943334 |
| | Virus-specific cytolytic cells. Their in vivo function | Q40108295 |
| | Induction, control and consequences of virus specific cytotoxic T cells | Q40262671 |
| | Inhibition of influenza-immune T cell effector function by virus-specific hybridoma antibody | Q40718469 |
| | Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth | Q43437738 |
| | Cytolytic T-cell mediated lysis of reovirus-infected cells: Requirements for infectious virus, viral particles, and viral proteins in infected target cells | Q45797290 |
| | Sendai virus-specific T cell clones II. Induction of interferon production by Sendai virus-specific T helper cell clones | Q45798947 |
| | High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies | Q45805052 |
| | T-cell cytotoxicity in the absence of viral protein synthesis in target cells | Q47965038 |
| | Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell | Q59064879 |
| | Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis | Q59070308 |
| | Evidence for functional domains on the reovirus type 3 hemagglutinin | Q72660964 |
| | T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections | Q72912507 |
| | CT hybridomas: tumor cells capable of lysing virally infected target cells | Q72932991 |
| | Host immune response to reovirus: CTL recognize the major neutralization domain of the viral hemagglutinin | Q72951640 |
| P433 | issue | 2-3 | |
| P304 | page(s) | 233-237 | |
| P577 | publication date | 1984-01-01 | |
| P1433 | published in | Survey of immunologic research | Q27713187 |
| P1476 | title | Recent developments in immunovirology | |
| P478 | volume | 3 | |